1.Bartus, R T, Dean, R, Beer, B and Lippa, A S. The Cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217 J: 408–17.
2.Perry, E, Tomlinson, B E, Blessed, Get al.Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978, ii: 1457–9.
3.Perry, E, Perry, R, Blessed, Get al.Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977; 1: 189.
4.Whitehouse, P J, Price, D L, Clark, A Wet al.Alzheimer's disease: evidence for selective loss of cholinergic neurons in nucleus basalis. Ann Neurol 1981; 10: 122–6.
5.Allain, H, Reymann, J M, Cognez, Pet al.Alzheimer's disease and the cholinergic hypothesis: an overview. In: Bes, A, ed. Senile dementias: early detection. John Libbey Eurotext: 1986.
6.Sherman, K A, Kumar, V, Ashford, J Wet al.Effect of oral physostigmine in senile dementia. In: Strong, Ret al, eds. Central Nervous Disorders of Ageing Clinical Intervention and Research. N.Y.: Raven Press, 1988.
7.Whitehouse, P J. Alzheimer's disease a multi-system disorder. Psychoparm Bull 1987; 23: 1, 15–18.
8.Izquierdo, I. The pathogenesis of the amnesia of Alzheimer's disease T.I.P.S. 1987; vol. 8.
9.Palmer, A M, Francis, P T, Benton, J Set al.Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem 1987; 48: 8–15.
10.Ebinger, G, Bruyland, M, Martin, J Jet al.Distribution of biogenic amines and their catabolites in brains from patients with Alzheimer's disease. J Neurol Sci 1987; 77: 267–83.
11.Gottfries, C G, Roos, B E and Winblad, B. Changes in the brain catecholamines in patients with dementia of the Alzheimer type. Br J Psychiat 1979; 135: 216–33.
12.Hunter, B, Zornester, S F, Jarvik, M Eet al.Modulation of learning and memory. In: Iversen, et al, eds. Handbook of Psychopharmacology, vol. 8. N.Y.: Plenum Press, 1977: 531–77.
13.Mason, S T. Noradrenaline in the brain: Progress in theories of behavioural function. Progr in Neurobiol 1981; 16: 264–95.
14.Anlezark, G M, Crow, T J and Greenway, A P. Impaired learning and decreased cortical norepinephrine after bilateral locus coeruleus lesions. Science 1973; 181: 682–4.
15.Zornester, S F and Gold, M. The locus coeruleus: Its possible role in memory consolidation. Physiol Behav 1976; 16: 331–6.
16.Chrobak, J C, DeHaven, D L and Walsh, T J. Depletion of brain norepinephrine with DSP4 fails to alter acquisition of performance of a radial arm maze task. Behav Neual Biol 1985; 44: 144–50.
17.Sara, S J and Segal, M. Locus Coeruleus in learning and memory retrieval. In: Matthies, , ed. Learning and Memory; Mechanisms of Information Storage in the Nervous System. N.Y.: Pergamon, 1986: 383–8.
18.Doty, B A and Doty, L A. Facilitative effects of amphetamine on avoidance conditioning in relation to age and problem difficulty. Psychopharmacologia; 9: 234–41.
19.Martinez, J L, Vasquez, B J, Rigter, Het al.Attenuation of amphetamine induced enhancment of learning by adrenal demedullation. Brain Res. 1980; 195: 433–43.
20.Gold, P E and Zornester, S F. The Mnemon and its juices: Neuromodulation of memory processes. Behav Neural Biol 38: 151–89.
21.Sara, S J and Devauges, V. Enhancement of cognitive function in the rat by alpha2 antagonists or electrical stimulation of locus coeruleus. Psychopharm 1986; 31.
22.Sara, S J. 1988. Personal communication.
23.Sara, S J. Noradrenergic modulation of selective attention: its role in memory retrieval. In: Olton, , Gamzu, and Corkin, eds. Memory Dysfunctions: an integration of animal and human research from clinical and preclinical perspectives. Ann NY Acad Sci 1985; 444: 178–93.
24.Waterhouse, B D and Woodward, D. Interaction of norepinephrine with cerebrocortical activity evoked by stimulation of somatosensory afferent pathway in the rat. Exp Neurol 1980; 67: 11–34.
25.Gold, P E and McGaugh, J L. Endogenous modulators of memory storage processes. In: Carenaza, et al, eds. Psychoneuroendocrinology in reproduction. London: Academic Press, 1978.
26.Wolkowitz, O M, Tinklenberg, J R and Weingarter, H A. Psychopharmacological perspectives of cognitive functions. Neuropsychobiol 1985; 14: 133–56.
27.Kety, S S. Brain catecholamines, affective states and memory. In: McGaugh, J L ed. The chemistry of mood, motivation and memory. N.Y.: Plenum Press, 1971: 65–80.
28.Leslie, F M, Loughlin, S E, Sternberg, O B, McGaugh, J L. Noradrenergic changes and memory loss in mice. Brain Res. 1985 359: 292–9.
29.Goodrick, C L. Learning retention and extinction of a complex maze habit for mature young and senescent wistar albino rats. J Gerontol 1968; 23: 298–304.
30.Bartus, R T, Fleming, D and Johnson, H R. Ageing in the rhesus monkey: debilitating effects on short term memory. J Gerontol 1978; 33: 858–71.
31.Dunnett, S B, Evenden, J L, Iversen, S. Delay dependent short term memory deficits in aged rats. Psychopharm 1988; 96: 174–80.
32.Arnsten, A F and Goldman-Rakic, P. Selective prefrontal cortical projections to the region of the loocus coeruleus and raphe nucleii in the rhesus monkey. Br Res 1984; 306: 9–18.
33.Goldman-Rakic, P S and Arnsten, A F T. Adrenergic agonists are cognitive enhancers in non-human primates. Clin Neuropharm 9, suppl 4: 292–4.
34.Hock, F J. Drug influences on learning and memory in aged animals and humans. Neuropsychobiol 1987; 17: 145–60.
35.McGeer, E G. Ageing and neurotransmitter metabolism in the human brain. Ageing 1978; 7.
36.Vijayashankar, N and Brody, H. A quantitative study of the pigmental neurons in the nuclei locus coeruleus and subcoeruleus in man as related to ageing. J Neuropath Exp Neurol 1979; 38: 490–7.
37.Bondareff, W, Mountjoy, C Q and Roth, M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Neurol 1982; 32: 164–8.
38.Berger, B, Tassin, J, Rancurel, Get al.Catecholaminergic innervation of the human cerebral cortex in presenile and senile dementia: Histochemical and biochemical studies. In: Usdin, et al, eds. Enzymes and neurotransmitters in mental disease. Chichester: John Wiley, 1980: 317–28.
39.Iversen, L, Rossor, M, Reynolds, Get al.Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of the Alzheimer's type. Neurosci Lett 1983; 39: 95–100.
40.Cross, A, Crowe, T, Perry, Eet al.Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J 1981; 282: 93–4.
41.Gottfries, C, Adolfsson, R, Aquiloniuss, Set al.Biochemical changes in dementia disorders of Alzheimer's type. Neurobiol Ageing 1983; 4: 261–71.
42.Mann, D, Yates, P and Marcynink, B. A comparison of changes in the nucleus basalis and locus coeruleus in Alzheimer's disease. J Neurol Neurosurg Psychiat 1984; 47: 201–3.
43.Decker, M W and Gallagher, M. Scopolamine disruption of radial arm maze performance, modification by noradrenergic depletion. Br Res 1987; 417: 59–69.
44.Moran, P and Leonard, B E. Effects of DSP4 pretreatment on scopolamine induced amnesia in the rat (abstract). J Psychopharm 1988; 2: 2.
45.Hollander, E, Mohs, R and Davis, K. Cholinergic approaches to the treatment of Alzheimer's disease. 1986. B Med Bull 42; 1: 97–100.